glp 1 for alcohol use Semaglutide weight loss was linked to a sharp drop in in this case report Does GLP-1 Stop Alcohol Cravings?

Ooi E et al

In March 2024, Novo Nordisk A/S stated that ozempic (semaglutide) 1.0 mg shows a 24% lower risk of kidney disease events in type 2 diabetes and chronic kidney disease in the FLOW trial

Hims recently pulled back on compounded drug sales, striking a deal with Novo in March to sell branded Wegovy and Ozempic and stop marketing compounds in exchange for Novo dropping a patent lawsuit

Boesen Law is actively investigating injury claims involving these widely used drugs: Reach out to our law firm for a no-cost, no-obligation consultation today

Pros: Fully virtual, easy to start, and HIPAA-compliant

Notably, older adults are more likely than their younger peers to have been told by a doctor that they have diabetes or heart disease